Obsidio, Inc. Expands Clinical Advisory Board With Two New Members
“It is an honor to welcome Drs. Jafar Golzarian and Marc Sapoval, who are distinguished clinicians and thought leaders in their respective disciplines, to Obsidio’s CAB,” stated Ehsan Jabbarzadeh, Ph.D., MBA, Co-Founder and CEO of Obsidio. “At Obsidio, we have an ambitious vision of developing a novel class of embolic materials that enable new treatment paradigms in interventional radiology and interventional oncology. The experience and insights of our CAB members will be critical to achieving that goal.”